Pneumonia Testing Market Expected to Reach $1,738 Million, Globally, by 2023
According to a new report published by Allied Market Research, titled, Pneumonia Testing Market by Method, Technology, Type, End User, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023, the pneumonia testing market accounted for $932 million in 2016, and is estimated to reach $1,738 million by 2023, registering a CAGR of 9.2% from 2017 to 2023.. North America is the highest contributor in the pneumonia testing market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.
Download PDF Sample Report: https://www.alliedmarketresearch.com/request-sample/3776
The global pneumonia testing market is segmented on the basis of market, by method, type, technology, end user, and region. In terms of method, the market is classified into immunodiagnostics, molecular diagnostics, and point-of-care (POC) testing. By type, it is bifurcated into analyzers and consumables. Based on technology, it is categorized into enzyme linked immunosorbent assay (ELISA), immunofluorescence, western blot, polymerase chain reaction (PCR), immunohistochemistry (IHC), and others. Depending on end user, it is divided into hospitals, diagnostic laboratories, homecare, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings of the Pneumonia Testing Market:
POC testing is projected to grow at the highest rate during the analysis period.
Diagnostic laboratories segment generated the highest revenue, and is expected to continue its dominance in future.
North America dominated global pneumonia testing market in 2016, and is projected to continue its dominance in future.
China is expected to grow highest in the Asia-Pacific region during the forecast period.
ELISA was the largest contributor among the technologies segments.
The key companies profiled in the report include Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.
Request Customization: https://www.alliedmarketresearch.com/request-for-customization/3776
Key Market Segments
By Type
Analyzers
Consumables
By End User
Hospitals
Diagnostic Laboratories
Homecare
Others
By Method
Immunodiagnostics
Molecular Diagnostics
Point of Care (POC) Testing
By Technology
Enzyme-linked Immunosorbent Assay (ELISA)
Immunofluorescence
Western Blot
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
Recent advancement in pneumonia testing systems such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor that contributes toward the growth of the pneumonia testing market. Moreover, increase in awareness toward early diagnosis and rise in government expenditures on healthcare fuel the market growth. However, limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, surge in adoption of molecular diagnostic testing and high untapped market potential in the developing economies are anticipated to provide lucrative opportunities for the market.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3776
Similar Reports:
Slide Stainer Market
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.